Table 2. Baseline Values and Effects of Propofol on Myocardial Performances and Coronary Blood Flow in the SHAM (n = 10) and in the Left Ventricular Hypertrophy Groups, LVH1(n = 10) and LVH2(n = 10)

Data are mean ± SD.

*P < 0.05 versus  baseline value.

P < 0.05 versus  left-ventricular hypertrophy with a “normal” left ventricular end-diastolic pressure (LVH1; baseline value only).

P < 0.05 versus  sham-operated group (SHAM; baseline value only).

LVEDP = left ventricular end-diastolic pressure; LVH2= left ventricular hypertrophy with a “high” LVEDP (see text for explanation); LVESP = left ventricular end-systolic pressure; NS = not significant; dP/dtmax, dP/dtmin= maximal positive- and negative-pressure derivatives; CBF = coronary blood flow.

Table 2. Baseline Values and Effects of Propofol on Myocardial Performances and Coronary Blood Flow in the SHAM (n = 10) and in the Left Ventricular Hypertrophy Groups, LVH1(n = 10) and LVH2(n = 10)
Table 2. Baseline Values and Effects of Propofol on Myocardial Performances and Coronary Blood Flow in the SHAM (n = 10) and in the Left Ventricular Hypertrophy Groups, LVH1(n = 10) and LVH2(n = 10)
Close Modal

or Create an Account

Close Modal
Close Modal